SCHEDULE: Vanguard Group Boosts Insulet Stake to 12.49%
Beneficial Ownership Report
The Vanguard Group has reported a 12.49% beneficial ownership stake in Insulet Corp, holding 8,796,200 shares of common stock.
Summary
- The Vanguard Group, an investment adviser, has filed an Amendment No. 13 to its Schedule 13G regarding its beneficial ownership in Insulet Corp.
- As of the event date of September 30, 2025, The Vanguard Group beneficially owns an aggregate of 8,796,200 shares of Insulet Corp's Common Stock.
- This aggregate amount represents 12.49% of the class of Insulet Corp's Common Stock.
- The Vanguard Group holds sole voting power over 0 shares and shared voting power over 425,744 shares.
- The firm holds sole dispositive power over 8,116,681 shares and shared dispositive power over 679,519 shares.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Insulet Corp.
Sentiment
Score: 7
Explanation: The filing indicates a significant, passive institutional ownership stake by The Vanguard Group in Insulet Corp, which can be viewed positively as a vote of confidence from a major asset manager.
Positives
- A significant ownership stake by a major institutional investor like The Vanguard Group can signal confidence in Insulet Corp's long-term prospects.
- The passive nature of the investment, as certified by Vanguard, indicates a stable, long-term holding rather than an activist position.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Insulet Corp's future performance or operations.
Management Comments
- Ashley Grim, Head of Global Fund Administration for The Vanguard Group, certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of Insulet Corp.
Industry Context
This filing is a routine disclosure of institutional ownership and does not provide specific insights into broader industry trends or competitive positioning for Insulet Corp.
Stakeholder Impact
- Shareholders and potential investors may view the significant, passive institutional ownership by The Vanguard Group as a positive indicator of stability and long-term investment interest in Insulet Corp.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of Event Which Requires Filing of this Statement |
| 10/30/2025 | Signature Date of the Filing |
Recommendation
holdThe Schedule 13G filing by The Vanguard Group indicates a significant, passive ownership stake in Insulet Corp. While a large institutional holder can be a positive signal, this filing primarily serves as a disclosure of ownership and does not provide new operational or financial data to warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on existing fundamental analysis.
Keywords
Insulet Corp, Vanguard Group, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Investment Adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.